Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.11 trillion and total revenue of $110 billion.
Market Cap
1.11T
Revenue
110B
Profits
-41.42B
PE Ratio
n/a
Profit Margin
-37.66%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.95B | 2.14% | 1,233,681 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.21B | 1.63% | 943,127 | 14.92B |
| 3 | ARGX | argenx SE | 55.58B | 4.26% | 357,397 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.64B | -0.63% | 1,061,443 | 4.29B |
| 5 | RPRX | Royalty Pharma plc | 31.84B | 1.41% | 3,072,974 | 2.44B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.73B | 3.50% | 2,201,974 | - |
| 7 | ONC | BeOne Medicines AG | 28.94B | -1.27% | 505,561 | 5.70B |
| 8 | BNTX | BioNTech SE | 22.64B | 3.93% | 3,494,447 | 3.23B |
| 9 | INCY | Incyte Corporation | 21.54B | 2.32% | 2,318,442 | 5.36B |
| 10 | ROIV | Roivant Sciences Ltd. | 21.38B | 4.65% | 4,507,174 | 8.26M |
| 11 | INSM | Insmed Incorporated | 20.96B | 5.27% | 5,105,458 | 819.56M |
| 12 | MRNA | Moderna, Inc. | 19.70B | 7.94% | 6,196,217 | 2.23B |
| 13 | GMAB | Genmab A/S | 15.30B | 3.06% | 1,173,452 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.82B | 2.85% | 954,534 | 4.44B |
| 15 | EXEL | Exelixis, Inc. | 13.45B | 1.75% | 1,823,031 | 2.38B |
| 16 | ASND | Ascendis Pharma A/S | 13.39B | 2.77% | 694,866 | 998.25M |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.23B | 0.21% | 2,535,039 | 579.96M |
| 18 | AXSM | Axsome Therapeutics, Inc. | 13.06B | 3.02% | 787,472 | 708.24M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.20B | 0.68% | 2,234,421 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.93B | 0.63% | 278,753 | 1.13B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.74B | -1.12% | 1,603,893 | 3.24B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.48B | 5.20% | 1,371,126 | 622.01M |
| 23 | SMMT | Summit Therapeutics Inc. | 10.15B | 0.23% | 9,289,765 | - |
| 24 | NUVL | Nuvalent, Inc. | 9.75B | 0.08% | 6,582,086 | - |
| 25 | KRYS | Krystal Biotech, Inc. | 9.48B | 2.92% | 475,186 | 417.30M |
| 26 | CYTK | Cytokinetics, Incorporated | 9.40B | 3.28% | 1,443,205 | 105.82M |
| 27 | CORT | Corcept Therapeutics Incorporated | 8.94B | 6.57% | 1,094,145 | 769.10M |
| 28 | TECH | Bio-Techne Corporation | 8.46B | 2.90% | 2,619,697 | 1.21B |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.39B | 0.33% | 1,344,180 | 1.51B |
| 30 | ABVX | ABIVAX Société Anonyme | 7.82B | 2.90% | 1,175,548 | 5.67M |
| 31 | IBRX | ImmunityBio, Inc. | 7.54B | 3.15% | 8,611,272 | 140.98M |
| 32 | PTGX | Protagonist Therapeutics, Inc. | 7.06B | 3.80% | 564,219 | 74.06M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 7.01B | 7.58% | 1,260,969 | - |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 6.91B | 3.04% | 428,873 | 7.46M |
| 35 | PCVX | Vaxcyte, Inc. | 6.83B | 4.12% | 2,039,015 | - |
| 36 | KYMR | Kymera Therapeutics, Inc. | 6.82B | 6.05% | 674,479 | 51.48M |
| 37 | TGTX | TG Therapeutics, Inc. | 6.81B | 3.07% | 2,531,312 | 700.35M |
| 38 | IMVT | Immunovant, Inc. | 6.75B | 5.45% | 1,203,760 | - |
| 39 | LEGN | Legend Biotech Corporation | 6.74B | 4.07% | 1,975,845 | 1.14B |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.71B | 8.20% | 792,670 | - |
| 41 | PTCT | PTC Therapeutics, Inc. | 6.20B | 1.85% | 2,245,423 | 827.11M |
| 42 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.20% | 871,057 | 15.00M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.07B | 5.89% | 687,766 | 569.61M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.01B | 2.28% | 684,067 | 217.17M |
| 45 | COGT | Cogent Biosciences, Inc. | 5.58B | 3.95% | 1,823,425 | - |
| 46 | BLTE | Belite Bio, Inc | 5.38B | 0.17% | 180,565 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.36B | 1.36% | 976,174 | - |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 5.10B | 2.55% | 274,594 | 274.48M |
| 49 | CAI | Caris Life Sciences, Inc. | 5.09B | 4.90% | 2,384,753 | 907.29M |
| 50 | CGON | CG Oncology, Inc. | 5.08B | 4.99% | 772,474 | 5.07M |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.04B | 1.66% | 1,727,197 | 7.50M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.84B | 1.60% | 1,514,711 | 4.10M |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.55B | 4.64% | 2,639,289 | 536.20M |
| 54 | CELC | Celcuity Inc. | 4.36B | 1.42% | 1,603,291 | - |
| 55 | ERAS | Erasca, Inc. | 4.36B | 4.79% | 5,704,055 | - |
| 56 | TNGX | Tango Therapeutics, Inc. | 4.31B | 3.97% | 6,446,055 | 56.99M |
| 57 | DNTH | Dianthus Therapeutics, Inc. | 4.18B | 0.04% | 1,441,847 | 1.34M |
| 58 | ORKA | Oruka Therapeutics, Inc. | 4.13B | 6.93% | 1,188,734 | - |
| 59 | MANE | Veradermics, Incorporated | 3.94B | 1.53% | 206,457 | - |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.10% | 1,020,825 | 596.96M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.66B | 0.66% | 945,091 | 1.10B |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 3.65B | 3.07% | 1,063,762 | - |
| 63 | PBLS | Parabilis Medicines, Inc. | 3.58B | -4.08% | 1,599,809 | - |
| 64 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.54B | -2.30% | 1,776,575 | 18.07M |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 3.54B | 3.10% | 2,053,070 | 22.57M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.34B | 1.99% | 1,964,652 | - |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.32B | 3.10% | 2,667,225 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.20B | 0.11% | 338,340 | 803.79M |
| 69 | RLAY | Relay Therapeutics, Inc. | 3.10B | 5.56% | 2,092,696 | 10.68M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.08B | 4.26% | 1,023,201 | - |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.08B | 5.85% | 2,748,967 | 415.62M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.97B | 1.58% | 1,980,824 | - |
| 73 | RCUS | Arcus Biosciences, Inc. | 2.93B | 5.33% | 1,285,269 | 236.00M |
| 74 | BEAM | Beam Therapeutics Inc. | 2.93B | -0.27% | 1,931,529 | 164.01M |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.69B | 2.19% | 399,703 | 535.08M |
| 76 | ALMS | Alumis Inc. | 2.66B | 4.19% | 1,705,312 | 8.40M |
| 77 | DFTX | Definium Therapeutics, Inc. | 2.63B | 3.74% | 2,369,187 | - |
| 78 | IRON | Disc Medicine, Inc. | 2.60B | 1.23% | 219,633 | - |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.53B | 4.49% | 1,361,746 | 225.27M |
| 80 | KLRA | Kailera Therapeutics, Inc. | 2.53B | 2.09% | 376,865 | - |
| 81 | ELVN | Enliven Therapeutics, Inc. | 2.46B | 9.08% | 5,099,623 | - |
| 82 | VERA | Vera Therapeutics, Inc. | 2.42B | 6.42% | 884,387 | - |
| 83 | RARE | Ultragenyx Pharmaceutical Inc. | 2.35B | 4.40% | 1,527,247 | 670.00M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 2.08% | 949,714 | 865.00K |
| 85 | PHVS | Pharvaris N.V. | 2.24B | 2.19% | 396,728 | - |
| 86 | KOD | Kodiak Sciences Inc. | 2.12B | 8.15% | 593,797 | - |
| 87 | IMNM | Immunome, Inc. | 2.08B | 1.10% | 2,002,585 | 4.02M |
| 88 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | 1.21% | 905,365 | 298.30M |
| 89 | HRMY | Harmony Biosciences Holdings, Inc. | 2.04B | -0.79% | 820,480 | 899.11M |
| 90 | NKTR | Nektar Therapeutics | 2.00B | 4.28% | 794,674 | 55.63M |
| 91 | ZLAB | Zai Lab Limited | 1.98B | 2.20% | 1,004,925 | 453.28M |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 1.98B | 0.76% | 1,544,229 | - |
| 93 | VCEL | Vericel Corporation | 1.97B | 3.18% | 505,196 | 292.09M |
| 94 | ADMA | ADMA Biologics, Inc. | 1.93B | -1.89% | 4,474,636 | 509.86M |
| 95 | TRVI | Trevi Therapeutics, Inc. | 1.91B | 0.45% | 641,867 | - |
| 96 | OCUL | Ocular Therapeutix, Inc. | 1.90B | -0.46% | 2,765,380 | 52.04M |
| 97 | LKFT | Lakefront Biotherapeutics NV | 1.89B | 1.01% | 161,242 | 1.20B |
| 98 | STOK | Stoke Therapeutics, Inc. | 1.83B | 3.09% | 498,438 | 32.08M |
| 99 | MESO | Mesoblast Limited | 1.79B | 2.32% | 104,246 | 65.38M |
| 100 | VRDN | Viridian Therapeutics, Inc. | 1.78B | 2.35% | 1,529,173 | 70.92M |
| 101 | MBX | MBX Biosciences, Inc. | 1.77B | 20.20% | 2,732,257 | - |
| 102 | IOVA | Iovance Biotherapeutics, Inc. | 1.77B | 4.76% | 11,510,806 | 285.61M |
| 103 | NRIX | Nurix Therapeutics, Inc. | 1.76B | 10.98% | 4,029,635 | 71.78M |
| 104 | NTLA | Intellia Therapeutics, Inc. | 1.73B | 1.23% | 7,935,809 | 66.09M |
| 105 | BHVN | Biohaven Ltd. | 1.71B | 2.71% | 4,384,768 | - |
| 106 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | -0.38% | 2,171,770 | 66.05M |
| 107 | NBTX | Nanobiotix S.A. | 1.69B | 4.04% | 84,361 | 38.27M |
| 108 | QURE | uniQure N.V. | 1.69B | - | 1,309,176 | 18.09M |
| 109 | RAPP | Rapport Therapeutics, Inc. | 1.68B | - | 1,063,276 | 20.00M |
| 110 | ZYME | Zymeworks Inc. | 1.68B | 0.50% | 1,109,330 | 81.26M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | 3.62% | 25,424,629 | 66.41M |
| 112 | GENB | Generate Biomedicines, Inc. | 1.66B | -1.75% | 511,541 | 30.30M |
| 113 | NUVB | Nuvation Bio Inc. | 1.66B | 3.93% | 3,457,391 | 143.05M |
| 114 | INVA | Innoviva, Inc. | 1.66B | -2.43% | 762,804 | 420.69M |
| 115 | SION | Sionna Therapeutics, Inc. | 1.63B | 5.94% | 398,960 | - |
| 116 | PGEN | Precigen, Inc. | 1.61B | 16.45% | 9,956,279 | 31.60M |
| 117 | ABCL | AbCellera Biologics Inc. | 1.61B | 3.54% | 4,170,894 | 79.21M |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.60B | 3.33% | 1,545,244 | 7.47M |
| 119 | FTRE | Fortrea Holdings Inc. | 1.60B | 3.24% | 1,240,655 | 2.71B |
| 120 | SNDX | Syndax Pharmaceuticals, Inc. | 1.59B | 1.88% | 1,579,377 | 217.17M |
| 121 | SRPT | Sarepta Therapeutics, Inc. | 1.58B | -0.73% | 2,758,816 | 2.18B |
| 122 | ANAB | AnaptysBio, Inc. | 1.58B | 4.11% | 525,215 | 232.39M |
| 123 | AAPG | Ascentage Pharma Group International | 1.58B | 0.23% | 1,670 | 82.08M |
| 124 | SEPN | Septerna, Inc. | 1.53B | 11.68% | 513,326 | 72.26M |
| 125 | PVLA | Palvella Therapeutics, Inc. | 1.53B | 4.10% | 210,912 | - |
| 126 | TYRA | Tyra Biosciences, Inc. | 1.52B | 0.59% | 1,298,263 | - |
| 127 | NVAX | Novavax, Inc. | 1.48B | 5.49% | 3,573,359 | 596.34M |
| 128 | IMCR | Immunocore Holdings plc | 1.46B | 2.58% | 412,681 | 412.81M |
| 129 | CAPR | Capricor Therapeutics, Inc. | 1.45B | -1.14% | 1,220,493 | 11.13M |
| 130 | GLUE | Monte Rosa Therapeutics, Inc. | 1.44B | 3.51% | 1,386,997 | 42.95M |
| 131 | SLS | SELLAS Life Sciences Group, Inc. | 1.44B | 8.39% | 6,268,357 | - |
| 132 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | - | - | 114.48M |
| 133 | URGN | UroGen Pharma Ltd. | 1.44B | 5.36% | 528,559 | 140.49M |
| 134 | VIR | Vir Biotechnology, Inc. | 1.44B | 3.27% | 1,371,701 | 65.50M |
| 135 | ARDX | Ardelyx, Inc. | 1.43B | 3.21% | 3,651,785 | 427.68M |
| 136 | GHRS | GH Research PLC | 1.42B | 1.47% | 220,235 | - |
| 137 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -0.95% | 432,455 | - |
| 138 | ATAI | AtaiBeckley Inc. | 1.40B | 0.53% | 4,858,494 | 3.49M |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.40B | 5.29% | 567,151 | - |
| 140 | MPLT | MapLight Therapeutics, Inc. | 1.38B | 9.17% | 255,453 | - |
| 141 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 4.55% | 359,492 | 1.30M |
| 142 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.35B | 2.56% | 2,740,813 | 204.73M |
| 143 | SVRA | Savara Inc. | 1.34B | 3.54% | 1,535,376 | - |
| 144 | MAZE | Maze Therapeutics, Inc. | 1.33B | 1.82% | 643,213 | 20.00M |
| 145 | DMRA | Damora Therapeutics, Inc. | 1.31B | 6.00% | 313,199 | - |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.31B | 1.49% | 726,205 | - |
| 147 | IMTX | Immatics N.V. | 1.24B | 2.14% | 236,577 | 43.00M |
| 148 | COAG | Hemab Therapeutics Holdings, Inc. | 1.19B | 4.70% | 190,950 | - |
| 149 | AVLN | Avalyn Pharma Inc. | 1.17B | -1.61% | 199,614 | - |
| 150 | MNKD | MannKind Corporation | 1.16B | 3.31% | 4,071,346 | 360.78M |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.12B | -0.84% | 607,217 | 10.00M |
| 152 | WVE | Wave Life Sciences Ltd. | 1.12B | 2.65% | 3,154,581 | 71.80M |
| 153 | AKTS | Aktis Oncology, Inc. | 1.08B | 4.74% | 137,059 | 8.28M |
| 154 | EYPT | EyePoint, Inc. | 1.05B | 1.38% | 1,260,368 | 7.61M |
| 155 | ABSI | Absci Corporation | 1.01B | 2.04% | 3,785,798 | 1.84M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 975.45M | 3.94% | 1,140,153 | - |
| 157 | DBVT | DBV Technologies S.A. | 962.97M | 3.12% | 92,219 | 5.74M |
| 158 | JBIO | Jade Biosciences, Inc. | 954.51M | 5.24% | 806,432 | - |
| 159 | SPRY | ARS Pharmaceuticals, Inc. | 952.32M | 3.56% | 989,799 | 98.99M |
| 160 | SPTX | Seaport Therapeutics, Inc. | 943.90M | 3.97% | 129,074 | - |
| 161 | XNCR | Xencor, Inc. | 896.37M | 2.20% | 500,302 | 97.36M |
| 162 | PHAR | Pharming Group N.V. | 894.01M | 4.89% | 2,396 | 369.49M |
| 163 | MGTX | MeiraGTx Holdings plc | 889.05M | 5.03% | 876,148 | 79.76M |
| 164 | DRTS | Alpha Tau Medical Ltd. | 872.90M | 4.76% | 700,809 | - |
| 165 | OLMA | Olema Pharmaceuticals, Inc. | 851.64M | -0.71% | 1,985,097 | - |
| 166 | TBPH | Theravance Biopharma, Inc. | 850.11M | 0.73% | 289,927 | 109.78M |
| 167 | ABUS | Arbutus Biopharma Corporation | 847.44M | 4.13% | 1,895,633 | 191.45M |
| 168 | LXRX | Lexicon Pharmaceuticals, Inc. | 839.53M | 0.53% | 2,041,413 | 69.64M |
| 169 | JANX | Janux Therapeutics, Inc. | 834.27M | 4.03% | 1,007,073 | 13.73M |
| 170 | LBRX | LB Pharmaceuticals Inc | 818.43M | 0.53% | 120,333 | - |
| 171 | PHAT | Phathom Pharmaceuticals, Inc. | 815.75M | 4.58% | 796,611 | 204.89M |
| 172 | ORIC | ORIC Pharmaceuticals, Inc. | 809.51M | 3.71% | 2,187,522 | - |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 797.73M | 7.72% | 1,216,234 | - |
| 174 | ODTX | Odyssey Therapeutics, Inc. | 793.00M | 3.77% | 212,672 | 2.98M |
| 175 | IVA | Inventiva S.A. | 792.25M | 0.53% | 831,749 | 7.94M |
| 176 | KURA | Kura Oncology, Inc. | 786.54M | 2.07% | 2,230,788 | 71.64M |
| 177 | SANA | Sana Biotechnology, Inc. | 770.87M | -1.77% | 2,951,970 | - |
| 178 | ANNX | Annexon, Inc. | 770.06M | -0.42% | 1,673,915 | - |
| 179 | ZVRA | Zevra Therapeutics, Inc. | 766.72M | -3.93% | 2,232,562 | 122.29M |
| 180 | VOR | Vor Biopharma Inc. | 763.48M | 8.38% | 1,045,273 | - |
| 181 | ANRO | Alto Neuroscience, Inc. | 752.06M | 8.89% | 336,770 | - |
| 182 | EVMN | Evommune, Inc. | 745.22M | 0.98% | 810,693 | 10.00M |
| 183 | OMER | Omeros Corporation | 736.78M | -0.20% | 1,097,428 | 9.89M |
| 184 | GERN | Geron Corporation | 731.33M | 3.64% | 31,745,972 | 196.12M |
| 185 | AVTX | Avalo Therapeutics, Inc. | 718.57M | 4.35% | 817,163 | 59.00K |
| 186 | REPL | Replimune Group, Inc. | 711.78M | 1.77% | 2,052,747 | - |
| 187 | SLDB | Solid Biosciences Inc. | 710.81M | 9.23% | 2,901,683 | - |
| 188 | CRMD | CorMedix Inc. | 702.93M | 2.17% | 1,237,832 | 400.05M |
| 189 | AURA | Aura Biosciences, Inc. | 684.96M | 1.47% | 816,602 | - |
| 190 | RLMD | Relmada Therapeutics, Inc. | 683.88M | 2.19% | 865,359 | - |
| 191 | OCS | Oculis Holding AG | 664.27M | 0.27% | 428,129 | 1.40M |
| 192 | DSGN | Design Therapeutics, Inc. | 657.67M | -1.22% | 696,584 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 648.89M | 5.62% | 6,102,343 | 22.00K |
| 194 | CTMX | CytomX Therapeutics, Inc. | 648.75M | 2.41% | 2,271,723 | 35.54M |
| 195 | TENX | Tenax Therapeutics, Inc. | 631.76M | 1.71% | 948,694 | - |
| 196 | ACRS | Aclaris Therapeutics, Inc. | 610.33M | 6.59% | 818,744 | 8.37M |
| 197 | CBIO | Crescent Biopharma, Inc. | 609.42M | 4.38% | 139,252 | 11.88M |
| 198 | SGP | SpyGlass Pharma, Inc. | 604.69M | 1.07% | 77,844 | - |
| 199 | DRUG | Bright Minds Biosciences Inc. | 601.15M | 0.02% | 582,739 | - |
| 200 | CADL | Candel Therapeutics, Inc. | 597.89M | -2.28% | 1,880,566 | - |
| 201 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 597.60M | 4.78% | 286,081 | - |
| 202 | TRAX | First Tracks Biotherapeutics, Inc. | 594.22M | 3.71% | 549,979 | - |
| 203 | RIGL | Rigel Pharmaceuticals, Inc. | 593.55M | 3.79% | 355,977 | 299.77M |
| 204 | ACHV | Achieve Life Sciences, Inc. | 566.68M | -4.00% | 2,771,019 | - |
| 205 | IMMX | Immix Biopharma, Inc. | 565.30M | -0.98% | 1,074,274 | - |
| 206 | GYRE | Gyre Therapeutics, Inc. | 553.71M | 1.68% | 75,104 | 117.05M |
| 207 | TECX | Tectonic Therapeutic, Inc. | 553.62M | 5.13% | 158,824 | - |
| 208 | MDXG | MiMedx Group, Inc. | 549.61M | 1.37% | 1,122,209 | 389.42M |
| 209 | XOMA | XOMA Royalty Corporation | 524.22M | 0.10% | 142,877 | 48.56M |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 522.60M | 0.76% | 1,010,456 | 151.40M |
| 211 | CLYM | Climb Bio, Inc. | 521.15M | 0.97% | 1,111,988 | - |
| 212 | PRME | Prime Medicine, Inc. | 509.34M | 4.06% | 2,502,532 | 4.03M |
| 213 | ALT | Altimmune, Inc. | 503.69M | -0.77% | 3,425,321 | 36.00K |
| 214 | PROK | ProKidney Corp. | 501.42M | -0.60% | 587,829 | 889.00K |
| 215 | CABA | Cabaletta Bio, Inc. | 490.79M | -0.99% | 3,127,179 | - |
| 216 | AGMB | AgomAb Therapeutics NV | 486.57M | -4.36% | 136,075 | - |
| 217 | VALN | Valneva SE | 483.84M | 0.57% | 19,406 | 180.25M |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 476.37M | 2.74% | 562,516 | - |
| 219 | FDMT | 4D Molecular Therapeutics, Inc. | 461.86M | 1.32% | 675,219 | 88.24M |
| 220 | EIKN | Eikon Therapeutics, Inc. | 459.64M | 1.56% | 248,150 | - |
| 221 | NGNE | Neurogene Inc. | 458.26M | 3.53% | 127,099 | 925.00K |
| 222 | ARVN | Arvinas, Inc. | 457.46M | 1.58% | 817,334 | 89.40M |
| 223 | ASMB | Assembly Biosciences, Inc. | 445.10M | 0.90% | 290,546 | 71.10M |
| 224 | CTNM | Contineum Therapeutics, Inc. | 443.78M | 5.04% | 127,409 | - |
| 225 | STRO | Sutro Biopharma, Inc. | 438.79M | 1.49% | 238,878 | 99.61M |
| 226 | PRTA | Prothena Corporation plc | 432.44M | 4.42% | 634,185 | 57.94M |
| 227 | CCCC | C4 Therapeutics, Inc. | 427.90M | - | 2,227,484 | 34.86M |
| 228 | FBRX | Forte Biosciences, Inc. | 425.18M | 3.45% | 172,223 | - |
| 229 | AUTL | Autolus Therapeutics plc | 415.18M | 5.41% | 923,484 | 92.62M |
| 230 | OCGN | Ocugen, Inc. | 413.00M | 2.52% | 4,858,313 | 4.47M |
| 231 | OVID | Ovid Therapeutics Inc. | 412.47M | -3.07% | 2,883,204 | 7.12M |
| 232 | PRLD | Prelude Therapeutics Incorporated | 407.62M | 4.05% | 204,867 | 16.72M |
| 233 | INDP | Indaptus Therapeutics, Inc. | 404.28M | 45.71% | 4,238,770 | - |
| 234 | IPSC | Century Therapeutics, Inc. | 403.99M | 5.66% | 692,838 | 109.16M |
| 235 | ANL | Adlai Nortye Ltd. | 403.60M | -3.63% | 109,965 | 5.00M |
| 236 | RZLT | Rezolute, Inc. | 403.24M | 1.31% | 1,151,073 | - |
| 237 | SGMT | Sagimet Biosciences Inc. | 397.06M | -1.08% | 763,642 | - |
| 238 | MNPR | Monopar Therapeutics Inc. | 395.86M | -0.55% | 79,071 | - |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 392.77M | 1.86% | 213,587 | - |
| 240 | VTVT | vTv Therapeutics Inc. | 392.02M | 4.27% | 30,977 | 36.84M |
| 241 | ARTV | Artiva Biotherapeutics, Inc. | 388.71M | 7.82% | 1,067,421 | 251.00K |
| 242 | BNTC | Benitec Biopharma Inc. | 379.62M | 6.35% | 189,222 | - |
| 243 | LRMR | Larimar Therapeutics, Inc. | 375.78M | 4.65% | 3,394,780 | - |
| 244 | EDIT | Editas Medicine, Inc. | 374.45M | -1.61% | 2,235,637 | 38.69M |
| 245 | PBYI | Puma Biotechnology, Inc. | 368.00M | 2.99% | 174,836 | 227.18M |
| 246 | VNDA | Vanda Pharmaceuticals Inc. | 366.83M | 1.16% | 991,927 | 217.78M |
| 247 | XFOR | X4 Pharmaceuticals, Inc. | 365.96M | 3.62% | 471,521 | 9.01M |
| 248 | CMPX | Compass Therapeutics, Inc. | 361.98M | 4.69% | 3,589,309 | 850.00K |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 347.72M | -1.03% | 175,480 | - |
| 250 | UPB | Upstream Bio, Inc. | 347.20M | 1.59% | 833,518 | 3.32M |
| 251 | VSTM | Verastem, Inc. | 346.22M | 4.79% | 1,534,154 | 49.59M |
| 252 | ZURA | Zura Bio Limited | 339.67M | 0.85% | 722,993 | - |
| 253 | OABI | OmniAb, Inc. | 339.24M | -1.68% | 311,790 | 28.94M |
| 254 | GLSI | Greenwich LifeSciences, Inc. | 338.04M | 4.16% | 55,537 | - |
| 255 | ENTA | Enanta Pharmaceuticals, Inc. | 334.69M | -1.58% | 263,173 | 69.21M |
| 256 | LXEO | Lexeo Therapeutics, Inc. | 329.79M | 1.69% | 591,141 | - |
| 257 | NMRA | Neumora Therapeutics, Inc. | 325.18M | 11.25% | 1,148,322 | - |
| 258 | RGNX | REGENXBIO Inc. | 324.66M | 2.45% | 1,393,600 | 87.82M |
| 259 | STTK | Shattuck Labs, Inc. | 320.52M | 1.21% | 940,426 | 1.00M |
| 260 | LYEL | Lyell Immunopharma, Inc. | 320.14M | 3.78% | 142,506 | 31.00K |
| 261 | LCTX | Lineage Cell Therapeutics, Inc. | 319.10M | 4.07% | 908,726 | 14.78M |
| 262 | IRD | Opus Genetics, Inc. | 318.26M | 0.51% | 553,681 | 11.98M |
| 263 | SLN | Silence Therapeutics plc | 315.53M | 11.33% | 700,918 | 839.00K |
| 264 | ABEO | Abeona Therapeutics Inc. | 315.18M | 3.17% | 1,077,284 | 14.54M |
| 265 | FENC | Fennec Pharmaceuticals Inc. | 307.42M | 1.72% | 213,557 | 51.00M |
| 266 | CNXU | Conexeu Sciences Inc. | 306.53M | -6.84% | 77,147 | - |
| 267 | PALI | Palisade Bio, Inc. | 298.02M | 5.95% | 3,093,950 | - |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 294.20M | 2.44% | 148,673 | - |
| 269 | RCKT | Rocket Pharmaceuticals, Inc. | 290.45M | 2.31% | 2,556,516 | - |
| 270 | NAUT | Nautilus Biotechnology, Inc. | 290.38M | 1.11% | 548,229 | - |
| 271 | BCYC | Bicycle Therapeutics plc | 286.23M | 1.74% | 651,388 | 63.50M |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 284.61M | 0.60% | 338,512 | 1.00 |
| 273 | NVCT | Nuvectis Pharma, Inc. | 278.78M | 1.94% | 62,701 | - |
| 274 | ELDN | Eledon Pharmaceuticals, Inc. | 275.97M | 3.18% | 767,528 | - |
| 275 | ARMP | Armata Pharmaceuticals, Inc. | 274.11M | -1.19% | 66,556 | 5.20M |
| 276 | NAGE | Niagen Bioscience, Inc. | 273.75M | -1.15% | 522,353 | 130.42M |
| 277 | SRZN | Surrozen, Inc. | 271.33M | 7.35% | 84,374 | 7.49M |
| 278 | IMRX | Immuneering Corporation | 266.55M | 5.10% | 2,191,940 | - |
| 279 | ELTX | Elicio Therapeutics, Inc. | 256.44M | -2.52% | 184,207 | - |
| 280 | MGNX | MacroGenics, Inc. | 254.89M | 3.62% | 712,658 | 157.08M |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 250.58M | -2.22% | 1,114,834 | 26.87M |
| 282 | IFRX | InflaRx N.V. | 247.45M | 3.70% | 613,835 | 33.82K |
| 283 | SLGL | Sol-Gel Technologies Ltd. | 246.16M | 2.45% | 44,951 | 18.47M |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 243.71M | 1.24% | 163,536 | 32.72M |
| 285 | HUMA | Humacyte, Inc. | 239.78M | -19.40% | 29,497,494 | 2.02M |
| 286 | IVVD | Invivyd, Inc. | 239.37M | -9.81% | 13,681,474 | 55.87M |
| 287 | FHTX | Foghorn Therapeutics Inc. | 238.38M | 5.45% | 317,769 | 28.22M |
| 288 | SABS | SAB Biotherapeutics, Inc. | 237.53M | 2.11% | 239,803 | 114.70K |
| 289 | RNAC | Cartesian Therapeutics, Inc. | 236.82M | 8.48% | 507,970 | 1.78M |
| 290 | FULC | Fulcrum Therapeutics, Inc. | 236.55M | 1.14% | 2,500,219 | 80.00M |
| 291 | ADAG | Adagene Inc. | 236.54M | 7.83% | 414,412 | 7.67M |
| 292 | AVXL | Anavex Life Sciences Corp. | 231.68M | 1.63% | 974,780 | - |
| 293 | CLLS | Cellectis S.A. | 230.57M | -2.83% | 74,677 | 75.11M |
| 294 | FATE | Fate Therapeutics, Inc. | 229.62M | 5.35% | 1,744,239 | 6.32M |
| 295 | YDES | YD Bio Limited | 228.54M | 4.67% | 10,933 | 510.36K |
| 296 | TRDA | Entrada Therapeutics, Inc. | 227.37M | 5.70% | 339,822 | 5.74M |
| 297 | ACIU | AC Immune SA | 224.19M | 6.60% | 444,208 | 4.62M |
| 298 | CAMP | Camp4 Therapeutics Corporation | 219.65M | -2.53% | 60,245 | 3.93M |
| 299 | CDXS | Codexis, Inc. | 219.06M | 2.55% | 414,000 | 78.09M |
| 300 | CHRS | Coherus Oncology, Inc. | 219.03M | 4.41% | 787,130 | 46.88M |
| 301 | QTTB | Q32 Bio Inc. | 215.35M | -1.32% | 437,955 | 53.74M |
| 302 | NERV | Minerva Neurosciences, Inc. | 215.24M | -1.07% | 107,703 | - |
| 303 | RNA | Atrium Therapeutics, Inc. | 212.11M | 6.26% | 282,515 | 36.68M |
| 304 | CNTN | Canton Strategic Holdings, Inc. | 210.81M | 2.37% | 1,171,081 | - |
| 305 | VYGR | Voyager Therapeutics, Inc. | 209.06M | 4.22% | 650,562 | 36.49M |
| 306 | UNCY | Unicycive Therapeutics, Inc. | 205.32M | - | 682,317 | - |
| 307 | TARA | Protara Therapeutics, Inc. | 205.15M | -3.44% | 1,468,284 | - |
| 308 | ALXO | ALX Oncology Holdings Inc. | 203.86M | 3.77% | 529,233 | - |
| 309 | LENZ | LENZ Therapeutics, Inc. | 203.80M | -1.22% | 972,602 | 20.99M |
| 310 | KPTI | Karyopharm Therapeutics Inc. | 202.96M | -1.21% | 200,225 | 151.12M |
| 311 | HELP | Cybin Inc. | 202.64M | 4.65% | 543,539 | - |
| 312 | WHWK | Whitehawk Therapeutics, Inc. | 200.78M | 1.00% | 117,080 | 7.15M |
| 313 | NGEN | NervGen Pharma Corp. | 200.72M | 9.25% | 1,260,258 | - |
| 314 | KROS | Keros Therapeutics, Inc. | 198.91M | 1.21% | 232,466 | 33.18M |
| 315 | ARCT | Arcturus Therapeutics Holdings Inc. | 198.11M | 1.16% | 316,365 | 54.71M |
| 316 | NKTX | Nkarta, Inc. | 197.47M | 12.20% | 1,174,318 | - |
| 317 | CGEN | Compugen Ltd. | 192.95M | 4.08% | 359,243 | 72.66M |
| 318 | MDWD | MediWound Ltd. | 181.09M | 1.66% | 74,829 | 14.48M |
| 319 | IMUX | Immunic, Inc. | 178.03M | 11.61% | 361,033 | - |
| 320 | EQ | Equillium, Inc. | 177.67M | 5.24% | 554,658 | 4.39M |
| 321 | TTRX | Turn Therapeutics Inc. | 174.56M | 5.97% | 29,897 | - |
| 322 | ALEC | Alector, Inc. | 174.31M | 3.29% | 428,202 | 18.42M |
| 323 | ENLV | Enlivex Ltd. | 173.31M | 6.90% | 184,614 | - |
| 324 | MIST | Milestone Pharmaceuticals Inc. | 172.78M | 4.10% | 1,058,077 | 1.78M |
| 325 | OKUR | OnKure Therapeutics, Inc. | 172.49M | 1.91% | 134,171 | - |
| 326 | GALT | Galectin Therapeutics Inc. | 171.89M | 9.66% | 304,644 | - |
| 327 | ABOS | Acumen Pharmaceuticals, Inc. | 171.18M | 5.80% | 255,073 | - |
| 328 | NBP | NovaBridge Biosciences | 170.00M | -3.92% | 442,568 | - |
| 329 | TNXP | Tonix Pharmaceuticals Holding Corp. | 169.77M | -2.83% | 1,055,297 | 17.56M |
| 330 | IPHA | Innate Pharma S.A. | 167.59M | 3.43% | 30,529 | 10.57M |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 165.17M | 4.06% | 602,883 | 76.38M |
| 332 | CRBU | Caribou Biosciences, Inc. | 164.64M | -7.26% | 2,704,755 | 11.20M |
| 333 | ANTX | AN2 Therapeutics, Inc. | 160.18M | 5.95% | 230,556 | - |
| 334 | DTIL | Precision BioSciences, Inc. | 159.20M | -4.34% | 432,207 | 45.07M |
| 335 | SPRO | Spero Therapeutics, Inc. | 156.33M | 6.30% | 1,156,442 | 61.19M |
| 336 | TNYA | Tenaya Therapeutics, Inc. | 156.20M | 3.08% | 2,911,690 | 225.00K |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 155.52M | 2.70% | 159,054 | 2.00M |
| 338 | KRRO | Korro Bio, Inc. | 151.87M | -0.57% | 83,045 | 3.84M |
| 339 | PRQR | ProQR Therapeutics N.V. | 151.72M | 2.13% | 346,139 | 15.73M |
| 340 | TLSA | Tiziana Life Sciences Ltd | 146.12M | -2.59% | 349,287 | - |
| 341 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 144.15M | 1.04% | 359,217 | - |
| 342 | KZIA | Kazia Therapeutics Limited | 143.29M | 9.04% | 352,053 | 1.27M |
| 343 | NRXP | NRx Pharmaceuticals, Inc. | 141.89M | 4.26% | 743,516 | 2.29M |
| 344 | MOLN | Molecular Partners AG | 141.62M | -0.27% | 797 | 856.30K |
| 345 | AGEN | Agenus Inc. | 141.17M | 10.42% | 1,214,733 | 123.87M |
| 346 | HURA | TuHURA Biosciences, Inc. | 139.46M | 5.29% | 198,369 | - |
| 347 | ADCT | ADC Therapeutics SA | 134.82M | -3.64% | 1,614,378 | 79.18M |
| 348 | SPRB | Spruce Biosciences, Inc. | 134.67M | 3.82% | 69,379 | 697.00K |
| 349 | OTLK | Outlook Therapeutics, Inc. | 132.95M | 23.60% | 43,929,529 | 333.14K |
| 350 | CNTB | Connect Biopharma Holdings Limited | 132.22M | 0.96% | 345,197 | 233.00K |
| 351 | ACOG | Alpha Cognition Inc. | 131.52M | 0.83% | 14,601 | 10.83M |
| 352 | CNTX | Context Therapeutics Inc. | 130.47M | -2.07% | 556,387 | - |
| 353 | GNLX | Genelux Corporation | 127.90M | 0.70% | 192,142 | 8.00K |
| 354 | MENS | Jyong Biotech Ltd. | 126.57M | -0.87% | 236,076 | - |
| 355 | ALPS | Alps Group Inc | 119.81M | 5.80% | 4,171 | 3.74M |
| 356 | GUTS | Fractyl Health, Inc. | 114.85M | -1.08% | 697,269 | 3.00K |
| 357 | NTHI | NeOnc Technologies Holdings, Inc. | 113.92M | -1.10% | 26,423 | 39.99K |
| 358 | PLYX | Polaryx Therapeutics, Inc. | 112.68M | 5.31% | 109,488 | - |
| 359 | ENGN | enGene Therapeutics Inc. | 109.86M | 2.50% | 492,987 | - |
| 360 | COYA | Coya Therapeutics, Inc. | 108.84M | 5.44% | 175,110 | 7.94M |
| 361 | CRDF | Cardiff Oncology, Inc. | 108.71M | 7.43% | 1,305,685 | 525.00K |
| 362 | CGTX | Cognition Therapeutics, Inc. | 107.22M | 5.26% | 604,327 | - |
| 363 | PYXS | Pyxis Oncology, Inc. | 105.80M | - | 806,082 | 13.86M |
| 364 | PEPG | PepGen Inc. | 104.45M | 9.42% | 631,293 | - |
| 365 | BDTX | Black Diamond Therapeutics, Inc. | 104.29M | -1.62% | 1,446,066 | 70.00M |
| 366 | KLRS | Kalaris Therapeutics, Inc. | 103.73M | 4.57% | 60,021 | - |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 103.50M | 4.78% | 38,224 | 37.16M |
| 368 | ALDX | Aldeyra Therapeutics, Inc. | 103.15M | 1.18% | 1,199,804 | - |
| 369 | PTHS | Pelthos Therapeutics Inc. | 99.82M | 4.74% | 41,817 | 27.70M |
| 370 | ONCY | Oncolytics Biotech Inc. | 97.87M | 2.49% | 1,673,693 | - |
| 371 | VANI | Vivani Medical, Inc. | 97.45M | - | 102,125 | - |
| 372 | PMN | ProMIS Neurosciences, Inc. | 95.95M | 4.90% | 6,030 | - |
| 373 | CBUS | Cibus, Inc. | 95.35M | 4.17% | 228,597 | 3.64M |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 94.25M | 6.09% | 43,153 | 23.14M |
| 375 | SEER | Seer, Inc. | 93.47M | 0.59% | 155,631 | 15.17M |
| 376 | FBIO | Fortress Biotech, Inc. | 91.68M | -0.36% | 392,863 | 66.16M |
| 377 | INO | Inovio Pharmaceuticals, Inc. | 90.13M | 0.92% | 1,418,976 | 65.34K |
| 378 | CSBR | Champions Oncology, Inc. | 89.15M | 12.24% | 11,162 | 57.95M |
| 379 | CUE | Cue Biopharma, Inc. | 88.19M | -2.76% | 43,573 | 32.73M |
| 380 | ICCC | ImmuCell Corporation | 88.12M | 0.72% | 10,938 | 29.93M |
| 381 | PYPD | PolyPid Ltd. | 87.63M | 1.33% | 103,101 | - |
| 382 | RNTX | Rein Therapeutics Inc. | 86.12M | 0.56% | 364,783 | - |
| 383 | BMEA | Biomea Fusion, Inc. | 86.04M | 3.48% | 775,276 | - |
| 384 | NRXS | NeurAxis, Inc. | 85.33M | 1.32% | 155,780 | 4.28M |
| 385 | LIXT | Lixte Biotechnology Holdings, Inc. | 84.23M | 5.22% | 442,108 | - |
| 386 | RLYB | Rallybio Corporation | 84.21M | -0.13% | 25,548 | 858.00K |
| 387 | ANIX | Anixa Biosciences, Inc. | 83.15M | 5.53% | 123,895 | - |
| 388 | HYFT | MindWalk Holdings Corp. | 81.45M | 1.86% | 278,951 | 20.70M |
| 389 | OKYO | OKYO Pharma Limited | 81.34M | 4.03% | 54,909 | - |
| 390 | RANI | Rani Therapeutics Holdings, Inc. | 80.05M | 2.43% | 564,224 | 3.17M |
| 391 | LONA | LeonaBio, Inc. | 79.94M | 0.95% | 12,411 | - |
| 392 | AARD | Aardvark Therapeutics, Inc. | 79.41M | 4.60% | 91,620 | - |
| 393 | ACET | Adicet Bio, Inc. | 79.28M | 3.28% | 42,075 | - |
| 394 | MAIA | MAIA Biotechnology, Inc. | 79.04M | 2.36% | 726,917 | - |
| 395 | ANVS | Annovis Bio, Inc. | 77.85M | 6.40% | 1,093,919 | - |
| 396 | HRTX | Heron Therapeutics, Inc. | 76.83M | -0.61% | 5,242,903 | 150.71M |
| 397 | OSTX | OS Therapies Incorporated | 76.16M | 1.18% | 365,053 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 72.09M | 3.05% | 533,983 | - |
| 399 | XBIT | XBiotech Inc. | 71.34M | -0.43% | 34,143 | - |
| 400 | ATHE | Alterity Therapeutics Limited | 71.19M | -0.96% | 33,573 | 4.43M |
| 401 | PLRX | Pliant Therapeutics, Inc. | 70.59M | -1.72% | 491,598 | - |
| 402 | BYSI | BeyondSpring Inc. | 67.85M | - | 9,813 | 1.88M |
| 403 | CING | Cingulate Inc. | 67.57M | 4.09% | 294,310 | - |
| 404 | EXOZ | eXoZymes, Inc. | 65.29M | -0.26% | 13,537 | -700.00 |
| 405 | IMA | ImageneBio, Inc. | 64.40M | 3.63% | 11,202 | 800.00K |
| 406 | MNOV | MediciNova, Inc. | 63.50M | 1.57% | 37,916 | 596.64K |
| 407 | FLNA | Filana Therapeutics, Inc. | 63.28M | -0.76% | 262,636 | - |
| 408 | PDSB | PDS Biotechnology Corporation | 62.51M | 5.66% | 593,428 | - |
| 409 | ACRV | Acrivon Therapeutics, Inc. | 61.63M | 4.35% | 330,907 | - |
| 410 | INKT | MiNK Therapeutics, Inc. | 61.45M | 1.19% | 108,830 | - |
| 411 | MCRB | Seres Therapeutics, Inc. | 60.72M | -3.39% | 85,262 | 1.15M |
| 412 | IBO | Impact BioMedical Inc. | 60.38M | -1.58% | 60,233 | 39.00K |
| 413 | TCRX | TScan Therapeutics, Inc. | 60.38M | 0.59% | 354,985 | 9.14M |
| 414 | IBIO | iBio, Inc. | 60.36M | -1.76% | 353,438 | 300.00K |
| 415 | PMVP | PMV Pharmaceuticals, Inc. | 58.13M | 2.83% | 368,450 | - |
| 416 | ENTX | Entera Bio Ltd. | 57.59M | -0.01% | 25,586 | 42.00K |
| 417 | TIL | Instil Bio, Inc. | 54.12M | - | 8,066 | - |
| 418 | DWTX | Dogwood Therapeutics, Inc. | 52.44M | 5.37% | 266,440 | - |
| 419 | VERU | Veru Inc. | 52.32M | 10.51% | 918,038 | 16.89M |
| 420 | LTRN | Lantern Pharma Inc. | 51.93M | 4.90% | 155,899 | - |
| 421 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.02M | 14.91% | 33,211 | - |
| 422 | EDSA | Edesa Biotech, Inc. | 50.20M | 8.45% | 508,802 | - |
| 423 | MREO | Mereo BioPharma Group plc | 49.77M | 2.33% | 2,961,061 | 500.00K |
| 424 | TVGN | Tevogen Bio Holdings Inc. | 48.87M | 10.09% | 14,744 | - |
| 425 | IMMP | Immutep Limited | 48.45M | 1.57% | 426,728 | 5.28M |
| 426 | XLO | Xilio Therapeutics, Inc. | 47.80M | 1.14% | 6,533 | 53.48M |
| 427 | ACTU | Actuate Therapeutics, Inc. | 47.61M | 2.05% | 49,768 | - |
| 428 | RADX | Radiopharm Theranostics Limited | 47.10M | 1.86% | 23,804 | 10.86M |
| 429 | MGX | Metagenomi Therapeutics, Inc. | 46.87M | 1.22% | 53,573 | 22.33M |
| 430 | ATYR | aTyr Pharma, Inc. | 46.61M | 1.49% | 1,230,487 | 190.00K |
| 431 | ESLA | Estrella Immunopharma, Inc. | 46.48M | 1.89% | 30,212 | - |
| 432 | KALA | KALA BIO, Inc. | 45.92M | 3.35% | 72,829 | - |
| 433 | GNTA | Genenta Science S.p.A. | 45.29M | 16.36% | 472,860 | - |
| 434 | TELO | Telomir Pharmaceuticals, Inc. | 43.32M | 1.61% | 82,002 | - |
| 435 | NTRB | Nutriband Inc. | 42.79M | 3.23% | 4,961 | 1.80M |
| 436 | GOSS | Gossamer Bio, Inc. | 41.64M | 13.72% | 22,657,751 | 55.54M |
| 437 | RNXT | RenovoRx, Inc. | 38.99M | 1.63% | 262,579 | 1.49M |
| 438 | GRDX | GridAI Technologies Corp. | 38.06M | -1.21% | 35,573 | - |
| 439 | HYPD | Hyperion DeFi, Inc. | 37.79M | 5.56% | 511,843 | 1.04M |
| 440 | PSTV | Plus Therapeutics, Inc. | 37.31M | 0.56% | 76,684 | 5.18M |
| 441 | GRCE | Grace Therapeutics, Inc. | 35.59M | -0.43% | 223,148 | - |
| 442 | INMB | INmune Bio Inc. | 33.76M | 4.96% | 235,542 | 50.00K |
| 443 | ABVC | ABVC BioPharma, Inc. | 33.10M | 1.55% | 33,567 | 797.92K |
| 444 | ALGS | Aligos Therapeutics, Inc. | 32.67M | 2.33% | 50,030 | 4.71M |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 32.63M | -0.95% | 134,180 | 90.00K |
| 446 | LSTA | Lisata Therapeutics, Inc. | 31.43M | -3.60% | 54,561 | 170.00K |
| 447 | NNVC | NanoViricides, Inc. | 31.21M | 2.24% | 160,503 | - |
| 448 | BOLD | Boundless Bio, Inc. | 31.16M | 0.72% | 37,494 | - |
| 449 | SNTI | Senti Biosciences Holdings, Inc. | 30.66M | 2.54% | 108,441 | 38.00K |
| 450 | DARE | Daré Bioscience, Inc. | 30.41M | 1.50% | 132,379 | 1.16M |
| 451 | EVAX | Evaxion A/S | 30.11M | -4.75% | 16,390 | 7.53M |
| 452 | APLM | Apollomics, Inc. | 30.09M | -0.65% | 8,860 | 8.84M |
| 453 | BRNS | Barinthus Biotherapeutics plc | 29.57M | 4.37% | 17,726 | 14.97M |
| 454 | SKYE | Skye Bioscience, Inc. | 28.08M | 2.50% | 337,443 | - |
| 455 | IGC | IGC Pharma, Inc. | 27.91M | 0.53% | 578,079 | 1.11M |
| 456 | KYNB | Kyntra Bio, Inc. | 27.37M | 1.05% | 6,294 | 7.44M |
| 457 | SER | Serina Therapeutics, Inc. | 26.97M | 4.02% | 1,143,952 | 130.00K |
| 458 | NRSN | NeuroSense Therapeutics Ltd. | 26.12M | 1.05% | 229,144 | - |
| 459 | QNTM | Quantum BioPharma Ltd. | 25.73M | 1.78% | 194,884 | - |
| 460 | TVRD | Tvardi Therapeutics, Inc. | 25.42M | 0.37% | 35,967 | - |
| 461 | PTN | Palatin Technologies, Inc. | 25.39M | 0.29% | 4,001 | 12.88M |
| 462 | LITS | Lite Strategy, Inc. | 25.17M | -0.63% | 394,148 | - |
| 463 | DYAI | Dyadic International, Inc. | 24.92M | -6.31% | 253,084 | 3.81M |
| 464 | PLUR | Pluri Inc. | 24.28M | -0.44% | 10,900 | 1.08M |
| 465 | NEUP | Neuphoria Therapeutics Inc. | 24.27M | 1.58% | 80,810 | -13.27K |
| 466 | LGVN | Longeveron Inc. | 24.02M | 0.12% | 228,363 | 1.22M |
| 467 | ALLR | Allarity Therapeutics, Inc. | 23.96M | 4.03% | 117,569 | 345.00K |
| 468 | BCTX | BriaCell Therapeutics Corp. | 23.92M | -4.86% | 422,224 | - |
| 469 | MRKR | Marker Therapeutics, Inc. | 22.84M | -4.20% | 156,346 | 3.55M |
| 470 | VTGN | Vistagen Therapeutics, Inc. | 22.71M | 7.10% | 958,918 | 789.00K |
| 471 | CRVO | CervoMed Inc. | 22.59M | 8.44% | 185,170 | 2.09M |
| 472 | ATOS | Atossa Therapeutics, Inc. | 22.26M | -41.25% | 1,419,877 | - |
| 473 | VYNE | VYNE Therapeutics Inc. | 22.16M | 0.94% | 33,553 | 454.00K |
| 474 | PLRZ | Polyrizon Ltd. | 21.68M | 4.70% | 34,387 | - |
| 475 | CELU | Celularity Inc. | 21.04M | -6.05% | 110,710 | 26.55M |
| 476 | KTTA | Pasithea Therapeutics Corp. | 20.32M | 4.79% | 127,484 | - |
| 477 | TRAW | Traws Pharma, Inc. | 19.24M | 1.60% | 268,105 | 2.73M |
| 478 | HOWL | Werewolf Therapeutics, Inc. | 19.16M | 8.00% | 809,254 | 1.14M |
| 479 | AEON | AEON Biopharma, Inc. | 18.28M | -2.13% | 43,162 | - |
| 480 | PASG | Passage Bio, Inc. | 18.01M | 9.45% | 56,991 | - |
| 481 | CLRB | Cellectar Biosciences, Inc. | 17.98M | -0.44% | 53,806 | - |
| 482 | XCUR | Exicure, Inc. | 17.97M | 2.17% | 14,794 | 500.00K |
| 483 | TPST | Tempest Therapeutics, Inc. | 17.93M | -1.57% | 41,418 | - |
| 484 | LPCN | Lipocine Inc. | 17.66M | 11.11% | 310,351 | 2.00M |
| 485 | NCEL | NewcelX Ltd. | 17.58M | 3.03% | 17,892 | - |
| 486 | CRIS | Curis, Inc. | 17.05M | -1.18% | 104,574 | 7.06M |
| 487 | AKTX | Akari Therapeutics, Plc | 16.96M | 1.30% | 82,580 | - |
| 488 | CVM | CEL-SCI Corporation | 16.09M | -5.93% | 478,108 | - |
| 489 | HIND | Vyome Holdings, Inc. | 16.00M | 4.83% | 13,168 | 152.72K |
| 490 | LEXX | Lexaria Bioscience Corp. | 15.89M | -2.30% | 71,073 | 368.00K |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 15.72M | 3.56% | 106,854 | 5.61M |
| 492 | GTBP | GT Biopharma, Inc. | 15.69M | 4.77% | 1,281,314 | - |
| 493 | QNCX | Quince Therapeutics, Inc. | 15.44M | 4.07% | 373,685 | - |
| 494 | MLEC | Moolec Science SA | 15.09M | 0.07% | 3,225 | 7.83M |
| 495 | OSRH | OSR Holdings, Inc. | 14.72M | 0.38% | 604,465 | 2.63M |
| 496 | SNSE | Sensei Biotherapeutics, Inc. | 14.48M | -5.43% | 71,144 | - |
| 497 | MBRX | Moleculin Biotech, Inc. | 14.41M | 8.00% | 196,320 | - |
| 498 | INAB | IN8bio, Inc. | 14.18M | 2.86% | 57,745 | - |
| 499 | TOVX | Theriva Biologics, Inc. | 14.09M | 26.08% | 290,080,246 | 300.00K |
| 500 | CALC | CalciMedica, Inc. | 14.04M | -4.29% | 241,927 | - |